|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||0.00 - 0.00|
|Beta (5Y monthly)||1.85|
|PE ratio (TTM)||N/A|
|Earnings date||27 Feb 2023 - 03 Mar 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Long-term investors looking to overcome the effects of inflation can find some satisfaction from quality growth stocks, especially from companies generating triple-digit growth in revenue and share-price appreciation. Shares of Inspire Medical Systems (NYSE: INSP), Axsome Therapeutics (NASDAQ: AXSM), and Abermarle (NYSE: ALB) can all be purchased for under $300. All three companies have had triple-digit percentage revenue and share-price growth over the past five years.
It's important to remember, though, that today's economic troubles and stock market downturn are temporary. Certain growth stocks may suffer in this sort of context. One is a medical technology company that's set to report record earnings.
Investors bought certain stocks hand over fist. In most cases, these particular companies offered investors a solid reason to be optimistic about their future. Up-and-coming biotech Axsome Therapeutics (NASDAQ: AXSM) commercialized its first two products.